Healthcare provider profile · identity verified

Cameron Phillips, FNP-C

Nurse Practitioner · WOLFEBORO, NH · NPI 1144759960

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	437	139
Levothyroxine Sodium	Levothyroxine Sodium	317	88
Lisinopril	Lisinopril	305	97
Amlodipine Besylate	Amlodipine Besylate	285	92
Omeprazole	Omeprazole	278	83
Gabapentin	Gabapentin	223	65
Alprazolam	Alprazolam	216	37
Losartan Potassium	Losartan Potassium	195	61
Pantoprazole Sodium	Pantoprazole Sodium	192	54
Metformin Hcl	Metformin Hcl	170	60
Furosemide	Furosemide	159	56
Metoprolol Succinate	Metoprolol Succinate	144	51
Rosuvastatin Calcium	Rosuvastatin Calcium	122	38
Fluticasone Propionate	Fluticasone Propionate	112	36
Montelukast Sodium	Montelukast Sodium	107	32
Hydrochlorothiazide	Hydrochlorothiazide	103	29
Tamsulosin Hcl	Tamsulosin Hcl	103	38
Albuterol Sulfate Hfa	Albuterol Sulfate	98	36
Jardiance	Empagliflozin	97	27
Lorazepam	Lorazepam	97	18
Ezetimibe	Ezetimibe	96	37
Metoprolol Tartrate	Metoprolol Tartrate	96	32
Prednisone	Prednisone	96	68
Pravastatin Sodium	Pravastatin Sodium	91	27
Meloxicam	Meloxicam	83	34
Eliquis	Apixaban	82	13
Tramadol Hcl	Tramadol Hcl	81	32
Sertraline Hcl	Sertraline Hcl	76	24
Carvedilol	Carvedilol	75	23
Ropinirole Hcl	Ropinirole Hcl	75	19
Trazodone Hcl	Trazodone Hcl	73	23
Simvastatin	Simvastatin	70	22
Metformin Hcl Er	Metformin Hcl	69	24
Potassium Chloride	Potassium Chloride	69	26
Glipizide Er	Glipizide	68	22
Ozempic	Semaglutide	64	11
Buspirone Hcl	Buspirone Hcl	58	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	12
Zolpidem Tartrate	Zolpidem Tartrate	57	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	15
Allopurinol	Allopurinol	54	16
Clopidogrel	Clopidogrel Bisulfate	54	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	54	25
Breo Ellipta	Fluticasone/Vilanterol	53	13
Diazepam	Diazepam	52	13
Methocarbamol	Methocarbamol	52	23
Fluoxetine Hcl	Fluoxetine Hcl	51	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	17
Duloxetine Hcl	Duloxetine Hcl	50	20
Farxiga	Dapagliflozin Propanediol	45	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	44	17
Xarelto	Rivaroxaban	44	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	42	14
Famotidine	Famotidine	42	22
Temazepam	Temazepam	42	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	13
Amitriptyline Hcl	Amitriptyline Hcl	38	suppressed
Bupropion Xl	Bupropion Hcl	38	11
Azithromycin	Azithromycin	36	33
Diclofenac Sodium	Diclofenac Sodium	36	16
Amoxicillin	Amoxicillin	35	32
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Clonazepam	Clonazepam	35	14
Fenofibrate	Fenofibrate Nanocrystallized	35	11
Spironolactone	Spironolactone	35	13
Celecoxib	Celecoxib	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Atenolol	Atenolol	31	11
Fenofibrate	Fenofibrate	31	13
Ondansetron Odt	Ondansetron	31	24
Venlafaxine Hcl Er	Venlafaxine Hcl	31	11
Glimepiride	Glimepiride	30	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	11
Cephalexin	Cephalexin	29	27
Donepezil Hcl	Donepezil Hcl	29	11
Lovastatin	Lovastatin	29	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Baclofen	Baclofen	27	suppressed
Ibuprofen	Ibuprofen	27	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	16
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	14
Naproxen	Naproxen	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Estradiol	Estradiol	23	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	21	suppressed
Nystatin	Nystatin	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Repatha Sureclick	Evolocumab	18	suppressed
Glipizide	Glipizide	17	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Finasteride	Finasteride	16	suppressed
Fluconazole	Fluconazole	16	12
Lansoprazole	Lansoprazole	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Topiramate	Topiramate	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	14
Hydrocortisone	Hydrocortisone	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Linzess	Linaclotide	14	suppressed
Mupirocin	Mupirocin	14	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Humalog Kwikpen U-200	Insulin Lispro	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Klor-Con M10	Potassium Chloride	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Promethazine Hcl	Promethazine Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error